David Skibinski

1.2k total citations
15 papers, 384 citations indexed

About

David Skibinski is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, David Skibinski has authored 15 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in David Skibinski's work include Immunotherapy and Immune Responses (4 papers), Influenza Virus Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). David Skibinski is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Influenza Virus Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). David Skibinski collaborates with scholars based in United States, Italy and Singapore. David Skibinski's co-authors include Derek T. O’Hagan, Simone Bufali, Manmohan Singh, Ben C. Berks, Simon C. Andrews, John R. Guest, Paul Golby, Frank Sargent, R. Harper and Margaret Attwood and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

David Skibinski

15 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Skibinski United States 11 128 123 91 81 48 15 384
William E. Sause United States 11 92 0.7× 253 2.1× 38 0.4× 242 3.0× 47 1.0× 15 456
Tomomitsu Sewaki Japan 9 104 0.8× 241 2.0× 122 1.3× 98 1.2× 38 0.8× 14 489
Paolo Emidio Costantini Italy 11 49 0.4× 265 2.2× 38 0.4× 42 0.5× 125 2.6× 19 507
Sandra Rivera Colombia 14 146 1.1× 101 0.8× 95 1.0× 93 1.1× 36 0.8× 32 537
Prabhjot Kaur India 7 36 0.3× 142 1.2× 74 0.8× 113 1.4× 31 0.6× 8 358
Sven Malm Germany 7 50 0.4× 147 1.2× 227 2.5× 226 2.8× 33 0.7× 9 423
Ya-Nan Dai China 10 75 0.6× 111 0.9× 112 1.2× 229 2.8× 11 0.2× 18 412
Christian Erick Palavecino Chile 11 122 1.0× 56 0.5× 208 2.3× 139 1.7× 11 0.2× 27 455
Maria Georgieva United States 12 112 0.9× 168 1.4× 175 1.9× 198 2.4× 62 1.3× 17 480
Jessica C. Seeliger United States 10 21 0.2× 293 2.4× 155 1.7× 203 2.5× 19 0.4× 24 481

Countries citing papers authored by David Skibinski

Since Specialization
Citations

This map shows the geographic impact of David Skibinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Skibinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Skibinski more than expected).

Fields of papers citing papers by David Skibinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Skibinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Skibinski. The network helps show where David Skibinski may publish in the future.

Co-authorship network of co-authors of David Skibinski

This figure shows the co-authorship network connecting the top 25 collaborators of David Skibinski. A scholar is included among the top collaborators of David Skibinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Skibinski. David Skibinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Carter, Darrick, et al.. (2025). The success of toll-like receptor 4 based vaccine adjuvants. Vaccine. 61. 127413–127413. 3 indexed citations
2.
Smith, Robin A.J., Erin M. Scherer, David Skibinski, et al.. (2025). Term immune memory responses to human papillomavirus (HPV) vaccination following 2 versus 3 doses of HPV vaccine. Vaccine. 50. 126817–126817. 1 indexed citations
3.
Bolouri, Hamid, Cate Speake, David Skibinski, et al.. (2021). The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. Journal of Clinical Investigation. 131(3). 22 indexed citations
4.
Smithmyer, Megan E., Alice Wiedeman, David Skibinski, et al.. (2021). A simple strategy for sample annotation error detection in cytometry datasets. Cytometry Part A. 101(4). 351–360. 1 indexed citations
5.
Skibinski, David, et al.. (2021). Frozen CyTOF panel enables robust and consistent longitudinal assessment of the SARS-CoV-2 immune landscape. The Journal of Immunology. 206(1_Supplement). 62.13–62.13. 1 indexed citations
6.
Li, Yongkai, Andrew T. Miller, Xiaoyue Zhang, et al.. (2016). Incorporation of Phosphonate into Benzonaphthyridine Toll-like Receptor 7 Agonists for Adsorption to Aluminum Hydroxide. Journal of Medicinal Chemistry. 59(12). 5868–5878. 36 indexed citations
7.
Valdés, Iris, David Skibinski, Ying Xiu Toh, et al.. (2015). Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice. Vaccine. 33(12). 1474–1482. 16 indexed citations
8.
9.
Skibinski, David, Brendon J. Hanson, Veronika von Messling, et al.. (2013). Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine. PLoS ONE. 8(10). e76571–e76571. 22 indexed citations
10.
Ugozzoli, Mildred, Donatello Laera, Sandra Nuti, et al.. (2011). Flow cytometry: An alternative method for direct quantification of antigens adsorbed to aluminum hydroxide adjuvant. Analytical Biochemistry. 418(2). 224–230. 28 indexed citations
11.
Bufali, Simone, et al.. (2011). Aluminum Adjuvant Dose Guidelines in Vaccine Formulation for Preclinical Evaluations. Journal of Pharmaceutical Sciences. 101(1). 17–20. 44 indexed citations
12.
Frigimelica, Elisabetta, Luisanna Zedda, David Skibinski, et al.. (2009). CT043, a Protective Antigen That Induces a CD4+Th1 Response duringChlamydia trachomatisInfection in Mice and Humans. Infection and Immunity. 77(9). 4168–4176. 24 indexed citations
13.
Galeotti, Cesira L., Pietro Lupetti, David Mercati, et al.. (2006). A Helicobacter pylori Vacuolating Toxin Mutant That Fails To Oligomerize Has a Dominant Negative Phenotype. Infection and Immunity. 74(3). 1786–1794. 29 indexed citations
14.
15.
Skibinski, David, Paul Golby, Yung‐Sheng Chang, et al.. (2002). Regulation of the Hydrogenase-4 Operon of Escherichia coli by the σ 54 -Dependent Transcriptional Activators FhlA and HyfR. Journal of Bacteriology. 184(23). 6642–6653. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William E. Sause Breakdown of academic impact, for papers by Tomomitsu Sewaki Breakdown of academic impact, for papers by Paolo Emidio Costantini Breakdown of academic impact, for papers by Sandra Rivera Breakdown of academic impact, for papers by Prabhjot Kaur Breakdown of academic impact, for papers by Sven Malm Breakdown of academic impact, for papers by Ya-Nan Dai Breakdown of academic impact, for papers by Christian Erick Palavecino Breakdown of academic impact, for papers by Maria Georgieva Breakdown of academic impact, for papers by Jessica C. Seeliger
Rankless by CCL
2026